Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Biomedicine & Biotechnology|May 24, 2012
MicroRNAs and induced pluripotent stem cells for human disease mouse modelingChingiz Underbayev, Siddha Kasar, Yao Yuan, et al.Leukemia Research and Treatment|December 22, 2012
MicroRNAs in Acute Myeloid Leukemia and Other Blood DisordersYao Yuan, Siddha Kasar, Chingiz Underbayev, et al.Molecular Immunology|May 15, 2012
Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupusYao Yuan, Siddha Kasar, Chingiz Underbayev, et al.Gigascience|October 2, 2019
IKAP-Identifying K mAjor cell Population groups in single-cell RNA-sequencing analysisYun-Ching Chen, Abhilash Suresh, Chingiz Underbayev, et al.Plos One|March 10, 2016
Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL)Siddha Kasar, Chingiz Underbayev, Moinuddin Hassan, et al.Stem Cells and Development|June 26, 2014
Reversible mitochondrial DNA accumulation in nuclei of pluripotent stem cellsJoel S Schneider, Xin Cheng, Qingshi Zhao, et al.Oncotarget|August 18, 2016
Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemiaChingiz Underbayev, Siddha Kasar, William Ruezinsky, et al.Blood|May 11, 2018
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib eraHannah R Robinson, Junpeng Qi, Erika M Cook, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor TherapyAnfal Alsadhan, Jonathan Chen, Erika M Gaglione, et al.Cancer Research|October 11, 2017
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic LeukemiaNakhle S Saba, Deanna H Wong, Georges Tanios, et al.Pageof 2